'Overturning established fact' leads to new new target in MLL-rearranged leukemia

(University of Colorado Anschutz Medical Campus) A University of Colorado Cancer Center paper published today in the journal Cancer Cell challenges existing understanding of potential therapeutic targets in MLL-translocation leukemia. Specifically, the study shows that within the family of MLL-related proteins, MLL2 and not MLL is the most appropriate target for drugs challenging the disease. In other words, drug developers aiming at MLL may have been missing slightly to one side of the real target.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news